Skip to main content
JS Link, Inc. logo

JS Link, Inc. — Investor Relations & Filings

Ticker · 127120 ISIN · KR7127120004 KO Manufacturing
Filings indexed 606 across all filing types
Latest filing 2020-05-15 Capital/Financing Update
Country KR South Korea
Listing KO 127120

About JS Link, Inc.

https://en.jslink.co.kr/

JS Link, Inc. is a company with dual operations in biotechnology and advanced materials manufacturing. Formerly known as DNA Link, Inc., its biotechnology division is a genome-based research and development firm. It specializes in genomic mass analysis technology, providing sequencing and analysis services for DNA, RNA, and other genomic data to advance personalized medicine. The company also operates a division dedicated to the manufacturing of high-performance sintered permanent magnets, which are produced using rare earth materials.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (DNAlink) announcing a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) regarding the supply of COVID-19 diagnostic kits. This type of disclosure is a standard regulatory announcement for material contracts. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-05-15 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (DNAlink) announcing a 'Single Sale/Supply Contract' for COVID-19 diagnostic kits. It details the contract value, duration, and counterparty information. Since this is a specific regulatory disclosure regarding a business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2020-05-15 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제8회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the 'Acquisition of Convertible Bonds before Maturity' (전환사채 발행후 만기전 사채 취득). This filing details the specific financial transaction where the company repurchased its own convertible bonds. Since this relates to capital structure changes and financing activities, it falls under the 'Capital/Financing Update' category.
2020-05-13 Korean
전환청구권행사(제8회차 CB)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (DNA Link) regarding the exercise of conversion rights for convertible bonds (CB). This type of filing details changes in capital structure due to the conversion of debt into equity, which falls under the 'Share Issue/Capital Change' category as it directly impacts the number of outstanding shares and the company's capital structure.
2020-05-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically a sale of shares) by an executive (Kang Seung-pyo) of DNA Link. This type of filing is a standard disclosure for insider trading or director/executive share dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2020-04-29 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 96% confidence The document is a formal regulatory disclosure regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by DNA Link. It details the contract value, counterparty (Boston University), and project scope. Since this is a specific regulatory announcement of a material business contract that does not fit into financial reporting or other specialized categories, it is classified as a Regulatory Filing (RNS).
2020-04-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.